marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Pacira BioSciences Balance Sheet 2011-2024 | PCRX
Annual Balance Sheet Pacira BioSciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
378 M | 594 M | -238 M | 220 M | 442 M | 158 M | 222 M | 209 M | 48.9 M | 65.6 M | 86.4 M | 46 M | -20.6 M |
Long Term Debt |
522 M | 689 M | 339 M | 313 M | 306 M | 291 M | 276 M | 109 M | - | - | - | 25.2 M | 18.5 M |
Long Term Debt Current |
8.8 M | 9.12 M | 7.89 M | 7.42 M | 4.94 M | - | - | - | 119 M | 120 M | 120 M | - | 7.04 M |
Total Non Current Liabilities |
- | - | - | - | 368 M | 307 M | 293 M | 128 M | 19.6 M | 14.9 M | 6.63 M | 32 M | 33.3 M |
Total Current Liabilities |
97.4 M | 148 M | 521 M | 253 M | 108 M | 60.7 M | 56.2 M | 44.8 M | 152 M | 140 M | 122 M | 14.2 M | 31.9 M |
Total Liabilities |
704 M | 906 M | 1.34 B | 655 M | 476 M | 368 M | 349 M | 172 M | 171 M | 155 M | 129 M | 46.2 M | 65.2 M |
Deferred Revenue |
- | - | - | - | - | - | 102 K | 595 K | 1.43 M | 1.43 M | 1.01 M | 972 K | 13.1 M |
Retained Earnings |
-107 M | -149 M | -212 M | - | -399 M | -388 M | -389 M | -346 M | -308 M | -310 M | -296 M | -233 M | -180 M |
Total Assets |
1.57 B | 1.68 B | 2.08 B | 1.27 B | 831 M | 689 M | 628 M | 391 M | 390 M | 326 M | 170 M | 112 M | 113 M |
Cash and Cash Equivalents |
153 M | 104 M | 586 M | 100 M | 78.2 M | 133 M | 54.1 M | 35.9 M | 57 M | 37.5 M | 12.5 M | 10.1 M | 46.2 M |
Book Value |
870 M | 775 M | 730 M | 620 M | 355 M | 321 M | 279 M | 219 M | 218 M | 171 M | 41.2 M | 65.9 M | 48.3 M |
Total Shareholders Equity |
870 M | 775 M | 730 M | 620 M | 355 M | 321 M | 279 M | 219 M | 218 M | 171 M | 41.2 M | 65.9 M | 48.3 M |
All numbers in USD currency
Quarterly Balance Sheet Pacira BioSciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
279 M | 480 M | 399 M | 399 M | 398 M | 397 M | 405 M | 405 M | 404 M | - | 403 M | 339 M | 326 M | 322 M | 317 M | 313 M | 313 M | 313 M | 313 M | 306 M | 306 M | 306 M | 306 M | 291 M | 291 M | 291 M | 291 M | 276 M | 276 M | 276 M | 276 M | 109 M | 108 M | 106 M | 105 M | 104 M | 104 M | 104 M | 104 M | 103 M | 103 M | 103 M | 103 M | - | - | 96.9 M | 95.9 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 18.5 M | 18.5 M | 18.5 M | 18.5 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
772 M | 768 M | 691 M | 704 M | 703 M | 734 M | 755 M | 906 M | 964 M | - | 1.18 B | 1.34 B | 637 M | 639 M | 637 M | 655 M | 655 M | 655 M | 655 M | 476 M | 476 M | 476 M | 476 M | 368 M | 368 M | 368 M | 368 M | 349 M | 349 M | 349 M | 349 M | 172 M | 172 M | 172 M | 172 M | 169 M | 169 M | 169 M | 169 M | 155 M | 155 M | 155 M | 155 M | 129 M | 129 M | 129 M | 129 M | 46.2 M | 46.2 M | 46.2 M | 46.2 M | 65.2 M | 65.2 M | 65.2 M | 65.2 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 102 K | - | - | 520 K | 595 K | 822 K | 1.05 M | 595 K | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 1.01 M | 1.01 M | 1.01 M | 1.01 M | 972 K | 972 K | 972 K | 972 K | 13.1 M | 13.1 M | 13.1 M | 13.1 M |
Retained Earnings |
-222 M | -78.9 M | -97.8 M | -107 M | -132 M | -143 M | -168 M | -149 M | -139 M | - | -158 M | -212 M | -207 M | -224 M | -244 M | -254 M | -254 M | -254 M | -254 M | -399 M | -399 M | -399 M | -399 M | -388 M | -388 M | -388 M | -388 M | -389 M | -389 M | -389 M | -389 M | -346 M | -346 M | -346 M | -346 M | -308 M | -308 M | -308 M | -308 M | -310 M | -310 M | -310 M | -310 M | -296 M | -296 M | -296 M | -296 M | -233 M | -233 M | -233 M | -233 M | -180 M | -180 M | -180 M | -180 M |
Total Assets |
1.52 B | 1.65 B | 1.58 B | 1.57 B | 1.53 B | 1.54 B | 1.52 B | 1.68 B | 1.73 B | - | 1.89 B | 2.08 B | 1.36 B | 1.33 B | 1.29 B | 1.27 B | 1.27 B | 1.27 B | 1.27 B | 831 M | 831 M | 831 M | 831 M | 689 M | 689 M | 689 M | 689 M | 628 M | 628 M | 628 M | 628 M | 391 M | 391 M | 391 M | 391 M | 388 M | 388 M | 388 M | 388 M | 326 M | 326 M | 326 M | 326 M | 170 M | 170 M | 170 M | 170 M | 112 M | 112 M | 112 M | 112 M | 113 M | 113 M | 113 M | 113 M |
Cash and Cash Equivalents |
246 M | 247 M | 184 M | 153 M | 99.1 M | 86.8 M | 35.5 M | 104 M | 109 M | 122 M | 227 M | 586 M | 134 M | 106 M | 66.7 M | 100 M | 100 M | 100 M | 100 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 133 M | 133 M | 133 M | 133 M | 54.1 M | 54.1 M | 54.1 M | 54.1 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 54.1 M | 57 M | 57 M | 57 M | 37.5 M | 37.5 M | 37.5 M | 37.5 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 10.1 M | 10.1 M | 10.1 M | 46.2 M | 46.2 M | 46.2 M | 46.2 M |
Book Value |
750 M | 879 M | 892 M | 870 M | 832 M | 808 M | 768 M | 775 M | 770 M | - | 710 M | 730 M | 719 M | 687 M | 651 M | 620 M | 620 M | 620 M | 620 M | 355 M | 355 M | 355 M | 355 M | 321 M | 321 M | 321 M | 321 M | 279 M | 279 M | 279 M | 279 M | 219 M | 219 M | 219 M | 219 M | 218 M | 218 M | 218 M | 218 M | 171 M | 171 M | 171 M | 171 M | 41.2 M | 41.2 M | 41.2 M | 41.2 M | 65.9 M | 65.9 M | 65.9 M | 65.9 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M |
Total Shareholders Equity |
750 M | 879 M | 892 M | 870 M | 832 M | 808 M | 768 M | 775 M | 770 M | 757 M | 710 M | 730 M | 719 M | 687 M | 651 M | 620 M | 620 M | 620 M | 620 M | 355 M | 355 M | 355 M | 355 M | 321 M | 321 M | 321 M | 321 M | 279 M | 279 M | 279 M | 279 M | 219 M | 219 M | 219 M | 219 M | 218 M | 218 M | 218 M | 218 M | 171 M | 171 M | 171 M | 171 M | 41.2 M | 41.2 M | 41.2 M | 41.2 M | 65.9 M | 65.9 M | 65.9 M | 65.9 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M |
All numbers in USD currency